Bioorganic and Medicinal Chemistry Letters p. 1311 - 1316 (1999)
Update date:2022-08-05
Topics:
Williams, Peter D.
Bock, Mark G.
Evans, Ben E.
Freidinger, Roger M.
Gallicchio, Steven N.
Guidotti, Maribeth T.
Jacobson, Marlene A.
Michelle S, Kuo
Levy, Michelle R.
Edward V, Lis
Michelson, Stuart R.
Pawluczyk, Joseph M.
Perlow, Debra S.
Pettibone, Douglas J.
Quigley, Amy G.
Reiss, Duane R.
Salvatore, Christopher
Stauffer, Kenneth J.
Woyden, Carla J.
Structure-activity studies on the oxytocin antagonist 1 (L-371,257; K(i) = 9.3 nM) have led to the identification of a related series of compounds containing an ortho-trifluoroethoxyphenylacetyl core which are orally bioavailable and have significantly improved potency in vitro and in vivo, e.g., compound 8 (L-374,943; K(i) = 1.4 nM).
View MoreContact:+86-134-5286-9121
Address:Add: Wing Tuck Commercial Centre, 177-183 Wing Lok Street, Hong Kong,
Wuxi Highness Chemical Co.,Ltd
website:https://www.phtpharmatech.com/
Contact:86-510-81771080
Address:No58 East Xinguan Rd, Guanlin Town, Yixing City, Jiangsu China
Jinan Xinke Pharmaceutical Science and Technology Co., Ltd.
Contact:+86 13256107535
Address:No. 592 the first gangxing road
Shanghai united Scientific Co.,Ltd.
Contact:+86-21-53535353
Address:28F No.900 huaihai Road Shanghai China
Guangzhou Chemical Reagent Factory
Contact:+86-20-8435 9820 or 8435 7345
Address:Southern Guangzhou, Guangdong, China
Doi:10.1021/ja00271a033
(1986)Doi:10.1002/cjoc.201090280
(2010)Doi:10.1055/s-0035-1562528
(2016)Doi:10.1007/BF00869027
()Doi:10.1021/jo00966a004
(1972)Doi:10.1007/BF00849353
()
